Herpes Zoster Vaccines
The two HZ vaccines, Zostavax and Shingrix, are effective in protecting individuals at highest risk of PHN. HZ vaccine access is predominantly limited to high-income countries because cost-effectiveness thresholds exclude them from nationa…
1 sources - 3 claims
The two HZ vaccines, Zostavax and Shingrix, are effective in protecting individuals at highest risk of PHN. HZ vaccine access is predominantly limited to high-income countries because cost-effectiveness thresholds exclude them from national immunisation programmes in low- and middle-income countries. The systematic review will examine vaccine-targetable risk factors as a secondary objective.